A. Fraissinette

Langerhans Cells of Human Mucosa

D. Schmitt, J. Thivolet, A. Fraissinette, 1989, The Journal of dermatology.

Assessment of the optimized SkinEthic Reconstructed Human Epidermis (RHE) 42 bis skin irritation protocol over 39 test substances.

Nathalie Alépée, Carine Tornier, Carole Amsellem, 2010, Toxicology in vitro : an international journal published in association with BIBRA.

In vitro tolerability of human nasal mucosa: histopathological and scanning electron-microscopic evaluation of nasal forms containing Sandostatin®

A. Pospischil, G. Fricker, J. Vonderscher, 1995, Cell Biology and Toxicology.

LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis.

P. Nussbaumer, A. Winiski, D. Roman, 2003, Biochemical pharmacology.

Ontogeny of Langerhans cells: phenotypic differentiation from the bone marrow to the skin.

D. Schmitt, J. Thivolet, C. Dezutter‐Dambuyant, 1990, Developmental and comparative immunology.

Assessment of the optimized SkinEthic Reconstructed Human Epidermis (RHE) 42 bis skin irritation protocol over 39 test substances.

C. Tornier, N. Alépée, C. Amsellem, 2010, Toxicology in vitro : an international journal published in association with BIBRA.

Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen.

A. Cordier, P. Ulrich, K. Coutant, 1999, Toxicological sciences : an official journal of the Society of Toxicology.

Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles

B. De Wever, S. Chibout, M. Rosdy, 1999, Cell Biology and Toxicology.